Diligence memo · auto-generated · as of July 3, 2026

New WORC (IX) Development & Management, LLC

New WORC (IX) Development & Management, LLC looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

New WORC (IX) Development & Management, LLC operates in Other Health Care, based in BELLINGHAM.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

New WORC (IX) Development & Management, LLC has raised $4.9M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $4.9M on 2010-04-20.

Most recent recorded round closed around 2010-04-20.

Valuation (modeled)modeled

Provath models New WORC (IX) Development & Management, LLC at approximately $98M (range $6.2M–$533M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.84× the median modeled value of Series A Other Health Care companies in 2010–2012 (199 peers) — value vs value, same stage and era. Within the normal band (84% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 16.2 yr ago; this sector typically re-raises about every 14 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 63% of Other Health Care peers (5377 compared).

Modeled value ranks above 79% of those peers.

Closest niche peers: Barrx Medical Inc, Icad Inc, Cas Medical Systems Inc, Cardiosolutions Inc, Ophthonix Inc.

Peoplefiled

1 named person on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.